Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
company
|
| gptkbp:acquisition |
multiple pharmaceutical companies
|
| gptkbp:advertising |
focus on innovation and quality
|
| gptkbp:awards |
numerous industry awards
|
| gptkbp:benefits |
comprehensive packages
|
| gptkbp:budget |
publicly available
|
| gptkbp:businessModel |
vertical integration
|
| gptkbp:category |
OTC drugs
medical devices prescription drugs vaccines biologics |
| gptkbp:CEO |
gptkb:Zhang_Wei
|
| gptkbp:certifications |
gptkb:ISO_9001
|
| gptkbp:challenges |
navigates competitive landscape
|
| gptkbp:clinicalTrials |
conducts extensive trials for new products
|
| gptkbp:community_engagement |
health education programs
|
| gptkbp:community_outreach |
supports local health initiatives
|
| gptkbp:competitors |
conducts regular market analysis
|
| gptkbp:culturalHeritage |
focus on teamwork and innovation
|
| gptkbp:customerBase |
hospitals and clinics
|
| gptkbp:customerService |
dedicated support team
|
| gptkbp:distributionChannels |
direct sales and partnerships
|
| gptkbp:employees |
over 5000
|
| gptkbp:established |
1995
|
| gptkbp:exportMarkets |
gptkb:Southeast_Asia
|
| gptkbp:financial_aid |
strong balance sheet
|
| gptkbp:financialPerformance |
consistent growth
|
| gptkbp:founded |
1995
|
| gptkbp:future_plans |
long-term growth focus
expand product lines and markets |
| gptkbp:global_presence |
expanding internationally
|
| gptkbp:governance |
transparent practices
|
| gptkbp:headquarters |
gptkb:Yiyang,_Hunan,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Yiyang Group
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:innovation |
focus on new drug development
|
| gptkbp:investmentFocus |
in technology and infrastructure
active communication with shareholders |
| gptkbp:market |
gptkb:China
leading_pharmaceutical_company_in_Hunan |
| gptkbp:notableFeature |
strong in the pharmaceutical sector
|
| gptkbp:partnerships |
various international firms
with research institutions |
| gptkbp:patentCitation |
holds numerous patents for drugs
|
| gptkbp:productionLocation |
multiple_locations_in_China
|
| gptkbp:products |
medicines
|
| gptkbp:regulatoryCompliance |
meets national standards
|
| gptkbp:researchAndDevelopment |
strong focus
|
| gptkbp:revenue |
over 1 billion RMB
|
| gptkbp:services |
healthcare_solutions
|
| gptkbp:social_responsibility |
active in community health initiatives
|
| gptkbp:stockExchange |
002603
|
| gptkbp:subsidiary |
gptkb:Yiyang_Pharmaceutical_Co.,_Ltd.
|
| gptkbp:supplyChain |
efficient and reliable
|
| gptkbp:sustainability |
environmental initiatives
|
| gptkbp:targetMarket |
frequent new product introductions
|
| gptkbp:training |
ongoing professional development
|
| gptkbp:type |
public company
|
| gptkbp:usesTechnology |
embraces digital transformation
|
| gptkbp:website |
www.yiyang.com
|